Click Therapeutics to Participate in Cowen’s 6th Annual FutureHealth Conference

NEW YORK–(BUSINESS WIRE)–Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ solutions as medical treatments, today announced that David Benshoof Klein, founder and CEO, will participate in the Commercialization of Digital Therapeutics panel discussion at the Cowen 6th Annual FutureHealth Conference on Thursday, June 17, 2021 at 1:40pm ET.

About Click Therapeutics

Click Therapeutics, Inc. develops and commercializes software as medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click is progressing a broad pipeline of Digital Therapeutics™ across a variety of high-burden therapeutic areas, including Major Depressive Disorder (MDD), Schizophrenia, Acute Coronary Syndrome (ACS), Chronic Pain, Migraine, Insomnia, COPD, Obesity, and more. For more information, visit ClickTherapeutics.com.

Contacts

Investor Relations Contact
Jess Yu

Senior Associate, Strategic Finance

jyu@clicktherapeutics.com

Media Contact
Karen Sharma

MacDougall

ksharma@macbiocom.com
781-235-3060